期刊文献+

15d-PGJ_2对肝星状细胞增殖和凋亡的影响 被引量:7

Effect of 15d-PGJ_2 on proliferation and apoptosis of HSC-T6
暂未订购
导出
摘要 目的观察15d-PGJ2上调过氧化质体增殖物激活受体γ(PPARγ)表达以及对肝星状细胞(hepatic stellate cell,HSC)增殖凋亡的影响。方法体外培养HSC-T6细胞,取对数生长期的细胞,应用1、2、3μmol.L-1不同浓度的PPARγ激动剂15d-PGJ2作用24h,同时以不加药物只加无血清培养基做为对照组,24h后应用RT-PCR的方法观察分析各组间肝星状细胞PPARγ mRNA表达的变化,Western blot检测相应的胞质内NF-κB抑制蛋白表达。MTT检测HSC增殖,吖啶橙荧光染色观察细胞凋亡,流式细胞仪分析细胞周期。结果经15d-PGJ2处理的HSC细胞中PPARγ mRNA表达比例上调;胞质内NF-κB蛋白表达明显抑制。MTT结果显示不同浓度的15d-PGJ2对HSC-T6细胞的增殖均有抑制作用,以2μmol.L-1组最为明显;吖橙啶染色显示经PPARγ激动剂处理组凋亡细胞数明显增多,流式细胞仪结果显示15d-PGJ2处理组细胞产生了G1期阻滞作用。结论15d-PGJ2能够上调PPARγ表达并抑制HSC-T6增殖及诱导其凋亡,其诱导凋亡机制可能与抑制NF-κB活性有关。 Aim To evaluate the effect of 15d-PGJ2 on up-regulated expression of PPARγ and inducing HSC apoptosis and inhibiting HSC proliferation. Methods The rat liver stellate cell line (HSC-T6) was cultured in DMEM, and treated with PPARγ agonist 15d-PGJ2 of different concentrations. The expression of PPARγ mRNA was detected by RT-PCR. The protein expression of NF-κB was examined by Western blot. The cell proliferation rate of HSC-T6 was determined by MTF eolorimetric assay. The cell cycle and apoptosis ratio were measured using flow cyto -metry analysis. Results The proliferation rate of the rat liver stellate cell line (HSC-T6) was significantly inhibited by 15d-PGJ2 ( vs controls, P 〈 0.05 ). Especially in the concerntration of 2 μmol·L^-1 group the proliferation rate was markly decreased, Western blot showed that protein expression of NF-κB decreased in HSC treated with 15d-PGJ2. In addition, acridine orange fluorescence vital staining suggested the apoptotic rate was significantly increased in HSC treated with 15d-PGJ2. Flow cytometry suggested HSC treated with 15d-PGJ2 was blocked in G1 phase. Conclusion 15d-PGJ2 can inhibit the activity of NF-κB so to cut down proliferation of HSC and induce HSC apoptosis.
出处 《中国药理学通报》 CAS CSCD 北大核心 2007年第2期177-180,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No30271170)
关键词 15D-PGJ2 过氧化质体增殖物激活受体γ 肝星状细胞 凋亡 核因子ΚB 15d-PGJ2 PPARγ HSC apoptosis NF- κB
  • 相关文献

参考文献9

  • 1Gong W,Pecci A,Roth S,et al.Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble fas ligand[J].Hepatology,1998,28(2):492-502.
  • 2Burt A D.Cellular and molecular aspects of hepatic fibrosis[J].J Pathol,1993,170:105-14.
  • 3Di Sario A,Bendia E,Svegliati Baroni G,et al.Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production[J].J Hepatol,2002,37(5):584-91.
  • 4Lang A,Schoonhoven R,Tuvia S,et al.Nuclear factor kappa B in proliferation,activation,and apoptosis in rat hepatic stellate cells[J].J Hepatol,2000,33(1):49-58.
  • 5张绪富,吕志平,刘晓燕.以肝星状细胞为靶标的抗肝纤维化治疗进展[J].中国药理学通报,2003,19(6):622-626. 被引量:17
  • 6Lang A,Brenner D A.Gene regulation in hepatic stellate cell[J].Ital J Gastroenterol Hepatol,1999,31(2):173-9.
  • 7Gong W,Pecci A,Roth S,et al.Transformation dependent susceptibility of rat hepatic stalemate cells to apoptosis induced by soluble fas ligand[J].Hepatology,1998,28(2):492-502.
  • 8Hellerband C,Jobin C,Limuro Y,et al.Inhibition of NF in activated rat hepatic stellate cells by proteasome inhibitors and an IκB superrepressor[J].Hepatology,1998,27:1285-95.
  • 9Miyahara T,Schrum L,Rippe R,Xiong S,Peroxisome proliferator-activated receptors and hepatic stellate cell activation[J].J Biol Chem,2000,275(46):35715-22.

二级参考文献37

  • 1[1]Parola RJ, Leonarduzzi G, Biasi F et al. Vitamin E dietary supplementation protects against carbon tetrachloride-inductd chronic liver damage and cirrhosis. Hepatology, 1992;16(4):1014~21
  • 2[2]Boigk G, Stroedter L, Herbst H et al. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bilt duct obliteration in rats. Hepatology, 1997;26(3):643~9
  • 3[3]Pares A, Planas R, Torres M et al. Effcts of silymarin in alcoholic patients with cirrhosis of the liver:Results of a controlled, doublt-blind, randomized and multicenter trial. J Hepatol, 1998;28(4):615~21
  • 4[4]Aleynik SI, Leo MA, Ma X et al. Polyenylphosphatidylcholine prevents carbon tetrachloride-inductd lipid peroxidation while it attenuates liver fibrosis. J Hepatol, 1997:27(3): 554~61
  • 5[5]Poniachik J, Baraona E, Zhao J, Lieber CS. Dili-noleoylphosphatigylcholine decrease hepatic stellate cell activation. J Lab Clin Med, 1999;133:342~8
  • 6[6]Cutrin C, Menino MJ, Otero X et al. Effect of nifedipine and S-adenosylmethionine in the liver of rat treated with CCl4 and ethanol for one month. Life Sci, 1992;51:113~8
  • 7[7]Muriel P, Castro V. Effects of S-adenorsyl-L-methionine and interferon-alph2b on liver damage induced by bile duct ligation in rats. J Appl Toxicol, 1998;18(2):143~7
  • 8[8]Okuno M, Moriwaki H, Muto Y, Kojima S. Protease inhibitors suppress TGF-beta generation by hepatic stellate cells. J Hepatol, 1998;29(6):1031~2
  • 9[9]Ueki T, Kaneda Y, Tsutsui H et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med, 1999;5(2): 226~30
  • 10[10]Baroni GS, D'Ambrosio L, Curto P et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology, 1996;23(5): 1189~99

共引文献16

同被引文献95

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部